A Multicenter Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel When Used to Treat Actinic Keratoses (AKs) on the Non Head Locations
NCT00742391
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
255
Enrollment
INDUSTRY
Sponsor class
Conditions
Actinic Keratoses
Interventions
DRUG:
PEP005 (ingenol mebutate) Gel
DRUG:
Vehicle gel
Sponsor
Peplin